BREAST LOBULAR CARCINOMA IN SITU
Clinical trials for BREAST LOBULAR CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST LOBULAR CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST LOBULAR CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a gel help fight breast cancer? early trial underway
Disease control OngoingThis early-phase trial is testing whether a gel form of the drug endoxifen can be safely applied to the skin in women scheduled for breast surgery. The study includes 32 women with various stages of breast cancer or high genetic risk. Researchers are checking for skin reactions a…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
Could a Lower-Dose pill be just as good for early breast cancer?
Disease control TerminatedThis study compares a low dose of tamoxifen with standard hormone therapies (like aromatase inhibitors) in postmenopausal women with a low-risk, hormone-positive, HER2-negative early breast cancer. The goal is to see if the low-dose option works just as well to prevent cancer fro…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC